ISRG Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (ISRG) trend channel, buy level and 3-month target on Trade The Path. Sector: Healthcare. Listed on NASDAQ. Levels below are fitted to this ticker's own swing highs and lows (Theil–Sen, log-price), then projected 3 months. On this symbol, 8 comparable calls have settled; 75% reached the published sell target. Information only, not financial advice.
Mid-channel, falling on both timeframes
Price is between the two trend lines. Nothing to act on yet.
Read from the last 12 months of history we hold: falling, drifting −38% a year. The target of US$618.14 sits above the nearest ceiling (US$405.45), so reaching it means breaking a line this stock has repeatedly turned at. What would overturn this: a close below US$293.30 — the floor of the channel being read — after which the trend, not the entry, is what was wrong.
- 12 months read from
- US$292.92 – US$405.45 Falling channel, −38% a year
- Position in that channel
- 79% 0% at the floor, 100% at the ceiling
What broke this trend
- The fall
- -46% from US$610.4022 Jan 2025 → 23 July 2026
- Whose problem it was
- This companyno peer group to compare against
- Does it resolve?
- Temporary falls like it have resolved on the record
- Regained so far
- 16%of what it lost
- What the record says
- 72% of 767 comparable falls came back, typically in 103 days measured across every stock we hold history for, its peer group being too small
The trend broke in January 2025: price fell 46% from 610.40 to 332.01 by July 2026, and has regained 16% of that fall since. Its peers did not fall with it, so this was about the company rather than its sector. The wire that week: “A Closer Look at Intuitive Surgical's Options Market Dynamics”. Falls like it have resolved: falls of about 46% here have come back to the old high 72% of the time (767 comparable falls), typically in 103 days. On that record the fall is treated as temporary, and the trend lines are fitted to the regime it created rather than through it. Priced from that: 618.14 within 295 days, reached 72% of the time in 767 comparable falls — about 0.22% a day held.
The buy and sell prices below are priced off this recovery rather than off the channel: it is the better expected return per day held once each is charged for the odds of working.
Reported at the time: A Closer Look at Intuitive Surgical's Options Market Dynamics — 17 Jan 2025
Price history, with the path projected 3 months forward
- Daily close
- Upper trend line (12 months)
- Lower trend line (12 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy at or below
US$377.20
level as at 16 Sept 2026
Our target
US$618.14
by 8 July 2027
Projected move
63.9%
gross, before costs
Price sits between our buy level and our target.
The trend broke in January 2025: price fell 46% from 610.40 to 332.01 by July 2026, and has regained 16% of that fall since. Its peers did not fall with it, so this was about the company rather than its sector. The wire that week: “A Closer Look at Intuitive Surgical's Options Market Dynamics”. Falls like it have resolved: falls of about 46% here have come back to the old high 72% of the time (767 comparable falls), typically in 103 days. On that record the fall is treated as temporary, and the trend lines are fitted to the regime it created rather than through it. Priced from that: 618.14 within 295 days, reached 72% of the time in 767 comparable falls — about 0.22% a day held. The entry is today's price, not a dip level: the fall is behind it and the evidence measured is what these recoveries paid from here, so waiting for a lower entry would be waiting for something the record does not say is coming. Of 767 comparable falls across every stock we hold history for, 72% were back at the old high within 103 days of the low, and the ones that got there gave up about 15% along the way — so expect to be underwater before it works. The target is the median level they regained, which is short of the old high of 610.40 because not all of them saw it again. It is a prediction and it is revised the same way any other is: if price loses its 50-day trend and stays below it, the recovery is treated as failed rather than delayed.
On this stock's own history these rules produced 8 settled calls, of which 6 reached target (75%), with an average best move of 12%. See the full record.
- Upper line touches
- 4
- Lower line touches
- 2
- Fit confidence
- 70%
- Fitted
- 16 Sept 2026
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- David J. Rosa
- Employees
- 17,021
- Country
- US
Scorecard
Our own pillar scores, computed from the fundamentals below. They are not Morningstar ratings — that data is licensed and we do not redistribute it.
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$135.05B
- Enterprise value
- —
- Beta
- 1.47
- Avg volume
- 2.86M
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 328.57-603.88
- Exchange
- NASDAQ
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted statistically to past swing highs and lows and projected forward on the assumption the same rhythm continues. It often does not. This is information, not advice.